An economic evaluation of tiludronic acid treatment in Paget's disease of bone

PharmacoEconomics

Volumn 12, Issue 4, 1997, Pages 460-474

  Lafuma, Antoine ^a   Fagnani, Francis ^a   Meunier, Pierre J ^b  

^a CEMKA EVAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID; TILUDRONIC ACID;

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; ECONOMIC EVALUATION; FRACTURE; HUMAN; LAMINECTOMY; OSTEOARTHRITIS; PAGET BONE DISEASE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030881212     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199712040-00004     Document Type: Article

References (27)

1. Meunier PJ. Bone histomorphometry and skeletal distribution of Paget's disease of hone. Semin Arthritis Rheum 1994; 23 (4): 219-21
2. Detheridge FM, Guyer PB, Barker DJP. European distribution of Paget's disease'of bone. BMJ 1982; 285: 1005-8
3. Kanis JA. Pathophysiology and treatment of Paget's disease of bone. London: Martin Dunitz, 1991
4. Collins OH. Paget's disease of bone: incidence and subclinical forms. Lancet 1956; 2: 51-7
5. Rauïs A. Etude statistique sur la maladie de Paget, ses complications et leur traitement. Acta Orthop Belg 1974; 40 (4): 499-530
6. Kaplan FS. Paget's disease of bone: orthopedic complications. Semin Arthritis Rheum 1994; 23 (4): 250-2
7. Roux C, Gesmari C, Farrenais J. Comparative prospective, double-blind, multicemer study of the efficacy of tiludronale and etidronate in the treatment of Paget's disease of bone. Arthritis Rheum 1995; 38 (6): 851-858
8. Ravault A, Meunier PJ. Suivi au long cours de 88 pagéliques traités par l'Etidronate disodique en cures discontinues à faible posologie. Rev Rhum Ed Fr 1989; 56 (4): 293-302
9. Allman RD. Long term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone. Am J Med 1985; 79: 583-5
10. Johnston CC, et al. Use of etidronate (EHDP) in Paget's disease of bone. Arthritis Rheum 1980; 23: 1172-6
11. Meunier PJ. Therapeutic strategy in Paget's disease of bone Bone 1995; 17 Suppl.: 489S-91S
12. Coutris G, Gayla J, Rondier J, et al. Analyse des perturbations des voies principales du métabolisme calcique dans la maladie de Paget. Rev Rhum Ed Fr 1975; 42 (12): 759-67
13. Guyer PB, Chamberlain AT, Ackery DM, et al. The anatomic distribution of osteitis deformans. Clin Orthop 1981; 156: 141-4
14. Nomenclature Générale des Actes Professionels. Paris: LICANSS, 1994
15. Bidner S, Finnegan M. Femoral fractures in Paget's disease. J Orthop Trauma 1989; 3 (4): 317-22
16. Bradley CM, Nades S. Outcome after fractures of the femur in Paget' s diseuse. Aust N Z J Surg 1992; 62: 39-44
17. Farre JM, Delcambre B. Conséquences fonctionnelles et complications de la maladie de Paget. Rev Prat 1989; 39 (13): 1129-36
18. Histogrammes et références par GHM. Hôpitaux publics et PSPH de la base nationale. Paris: Ministère des Affaires Sociales, 1992
19. Bulletin Municipal Officiel de la Ville de Paris. Annexe 3. Paris: Municipal Officiel de la Ville de Paris, 1993 Dec: 1109
20. Ministère des Affaires Sociales. Les soins hospitaliers en France: clientèle, pathologies traitées en court séjour, chiffres repères. Paris: Ministère des Affaires Sociales, 1992
21. Sourly-Le Guellec MJ. Équipement, tarifs et occupation des lits dans les établissements hospitaliers publics ou faisant fonction de public. Paris: CREDES, 1991
22. Meunier PJ, Salson C, Mathieu L. Skeletal distribution and biochemical parameters of Paget's disease. Clin Orthop 1987; 217: 37-44
23. Howarth S. Cardiac output in osteitis deformans. Clin Sci 1953; 12: 271
24. Khairi MRA. Radiographs and scans in diagnosing symptomatic lesions of Paget's disease of bone (osteitis deformans). Gertatrics 1974; 29: 49
25. Johnston CC, Altman RD, Canfield RE, et al. Review of fracture experience during treatment ot Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop 1983; 172: 186-94
26. Sins ES, Canfield RF:. Jacobs TP, et al. Long-term therapy of Paget's disease of bone with EHDP. Arthritis Rheum 1980; 23: 1177-84
27. Siris ES, Canfield RE, Jacobs TP, et al. Clinical and biochemical effects of EHDP in Paget's disease of bone: pattern of response to initial treatment and to long-term therapy. Metab Bone Dis Relat Res 1981; 3: 301-8